Actively Recruiting
Study of Rifampicin Combined With Antibiotics for Treating Staphylococcal Periprosthetic Joint Infection After Surgery
Led by First Affiliated Hospital of Fujian Medical University · Updated on 2025-12-31
428
Participants Needed
1
Research Sites
24 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of rifampicin combined with antibiotics to treat periprosthetic joint infections PJI caused by staphylococcus bacteria. This multicenter, randomized controlled study focuses on patients who have undergone DAIR surgery and aims to compare infection control rates and safety between two treatment approaches over at least a two-year follow-up period. The study follows CONSORT guidelines and ensures ethical approval and informed consent from participants. After surgery, all patients receive intravenous antibiotics for 1 to 2 weeks. Then, they are randomly assigned to one of two groups one group receives conventional antibiotics fluoroquinolones or linezolid for 3 months based on microbial culture results, while the other group receives the same antibiotics plus oral rifampicin for 3 months. Both groups are monitored to assess the differences in infection control and safety outcomes. Participants will undergo regular assessments including infection recurrence rates, inflammatory markers, prosthesis function recovery, and monitoring for drug side effects. Data is collected through a unified system and analyzed at the studys end. The primary outcomes include infection clearance and adverse events related to PJI two years after surgery. Secondary outcomes include functional scores, prosthesis loosening, revision rates, prosthesis removal, and antibiotic complications. The study duration per participant covers at least two years of follow-up.
CONDITIONS
Brief Title
Rifampin-combined Antibiotic Therapy for Staphylococcal PJI
Research Team
X
Xinyu Fang, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here